Charla Baker-Jackson – Trademark Portfolio

Entity Type: 01

Charla Baker-Jackson holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BREATHE BABY BREATHE. The owner is based in Winnetka, CA.

8132 Quartz Avenue

Winnetka, CA 91306

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Charla Baker-Jackson's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Charla Baker-Jackson have?

Charla Baker-Jackson has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.

What trademark classes does Charla Baker-Jackson file in?

Charla Baker-Jackson files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 10 (Medical Apparatus). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are Charla Baker-Jackson's most well-known trademarks?

Charla Baker-Jackson's registered trademark portfolio includes well-known marks such as BREATHE BABY BREATHE. These are among 1 currently registered trademark in the portfolio.

What is Charla Baker-Jackson's trademark registration success rate?

Charla Baker-Jackson has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.